Stock APVO APTEVO THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Aptevo Therapeutics Inc.

Equities

APVO

US03835L3069

Market Closed - Nasdaq
Other stock markets
 03:59:50 2024-03-05 pm EST 		5-day change 1st Jan Change
5.694 USD -7.17% Intraday chart for Aptevo Therapeutics Inc. -13.10% -28.51%
Apr. 11 US Equity Markets Close Mixed After March Producer Price Inflation Data MT
Apr. 11 Top Midday Decliners MT

Chart calendar Aptevo Therapeutics Inc.

93a109f465af708f8bf7c2209b0f.O2u_ZCLvWkRocuqH8veVwgX6c2vol8J4p4tcP0g3tB8.UyHcM1DdHi49IIfEo5zMkjajSzub47EuxOEaEiV213wIMdFcV709IRFEhQ~ac15c18077b76c7904924004ef64b48d

Upcoming events on Aptevo Therapeutics Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-25 Q4 2024 Earnings Release (Projected)

Past events on Aptevo Therapeutics Inc.

2024-03-18 05:30 pm ROTH Conference
2024-03-05 08:05 am Q4 2023 Earnings Release
2024-02-05 01:00 pm Extraordinary Shareholders Meeting
2023-11-14 08:05 am Q3 2023 Earnings Release
2023-11-07 08:15 am Bio-Europe Conference
2023-08-10 08:05 am Q2 2023 Earnings Release
2023-06-02 01:00 pm Annual General Meeting
2023-05-11 08:05 am Q1 2023 Earnings Release
2023-03-30 07:45 am Q4 2022 Earnings Release
2022-12-11 American Society of Hematology Meeting - Poster No. APVO436
2022-11-10 08:05 am Q3 2022 Earnings Release
2022-08-11 08:05 am Interim 2022 Earnings Release
2022-06-07 01:00 pm Annual General Meeting
2022-05-12 08:05 am Q1 2022 Earnings Release
2022-04-11 American Association of Cancer Research Meeting - Poster No : APVO442
2022-03-24 08:05 am FY 2021 Earnings Release
2021-11-12 08:05 am Q3 2021 Earnings Release
2021-10-27 Euroleuk Congress
2021-08-12 08:05 am Interim 2021 Earnings Release
2021-07-19 11:25 am Cambridge Health Institute PEGS Virtual Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		32,4
33,1
-2.15%		4,31
3,68
17.07%		12,3
12,0
2.2%		3,11
3,11
0%		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-42,6
-46,1
7.55%		-27,5
-27,2
-1.21%		-21,4
-22,5
4.93%		-28,6
-29,0
1.08%		-28,9
-29,2
1.18%
-25,5

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-44,7
-47,0
4.83%		-30,9
-25,9
-19.42%		-29,4
-28,8
-1.96%		7,01
4,36
60.78%		-18,7
-18,0
-3.8%
-26,2

Net income
Million USD		Released
Forecast
Spread 		-40,4
-45,2
10.54%		-17,8
-16,8
-5.96%		-28,5
-28,8
1.33%		8,03
4,71
70.48%		-17,4
-18,2
4.27%
-25,5

EPS
USD		Released
Forecast
Spread 		-610
-698
12.65%		-230
-201
-14.57%		-267
-270
1.14%		69,1
40,9
68.82%		-62,5
-75,5
17.2%
-31,5

Announcement Date25/03/2031/03/2124/03/2230/03/2305/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		3,67
3,40
7.79%		3,11
3,75
-16.96%		0,00
3,43
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-4,04
-5,15
21.55%		-5,61
-4,57
-22.83%		-7,56
-5,88
-28.67%		-7,78
-7,59
-2.58%		-7,68
-8,00
3.93%		-7,76
-7,97
2.73%		-8,18
-8,00
-2.23%		-6,56
-8,91
26.4%		-6,38
-6,73
5.13%
-6,49


-6,52


-6,56


-6,59

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,60
-6,45
-2.29%		-7,88
-6,26
-25.89%		27,9
-5,53
603.91%		-7,81
-8,50
8.13%		-5,16
-8,06
35.95%		1,83
-7,92
123.06%		-7,95
-8,00
0.65%		-6,33
-8,48
25.29%		-6,20
-6,46
4.06%
-6,49


-6,52


-6,56


-6,59

Net income
Million USD		Released
Forecast
Spread 		-6,27
-6,45
2.75%		-7,70
-6,26
-23.04%		28,0
-5,53
606.6%		-7,64
-8,35
8.46%		-4,64
-7,96
41.69%		2,77
-7,82
135.44%		-7,95
-8,00
0.65%		-6,33
-8,86
28.54%		-5,90
-6,68
11.62%
-6,49


-6,52


-6,56


-6,59

EPS
USD		Released
Forecast
Spread 		-55,9
-57,0
1.93%		-68,2
-40,9
-66.67%		246
-48,8
602.7%		-66,0
-72,2
8.54%		-41,8
-67,3
37.91%		17,2
-52,1
132.91%		-54,1
-49,3
-9.82%		-22,0
-33,0
33.33%		-6,16
-18,0
65.85%
-11,6


-11,2


-6,14


-6,02

Announcement Date24/03/2212/05/2211/08/2210/11/2230/03/2311/05/2310/08/2314/11/2305/03/24----

Upcoming sector events for Aptevo Therapeutics Inc.

2024-04-23 07:30 am KINIKSA PHARMACEUTICALS, LTD.: Q1 2024 Earnings Release
2024-04-23 INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23 SINOCELLTECH GROUP LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23 SHANGHAI MEDICILON INC.: Q4 2023 Earnings Release
2024-04-24 04:05 pm VIKING THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 REMEGEN CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 HITGEN INC.: Q4 2023 Earnings Release
More events

Past sector events for Aptevo Therapeutics Inc.

Today BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected)
Today JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release
2024-04-12 SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release
2024-04-10 07:00 am NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-08 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release
2024-04-02 03:06 am TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release
2024-03-31 PEPTRON, INC.: Q4 2023 Earnings Release (Projected)
2024-03-31 BIONEER CORPORATION: Q4 2023 Earnings Release (Projected)
2024-03-29 08:30 am INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release
2024-03-28 BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. APVO Stock
  4. Calendar Aptevo Therapeutics Inc.